Walvax COVID-19 vaccine

Walvax COVID-19 Vaccine is a vaccine developed for the prevention of the COVID-19 disease, caused by the SARS-CoV-2 virus. The vaccine is developed by Walvax Biotechnology, a Chinese biopharmaceutical company.

Development

The Walvax COVID-19 Vaccine is based on the mRNA technology, similar to the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine. The mRNA technology uses a piece of the virus's genetic code to instruct cells to produce a protein that triggers an immune response.

Efficacy

The efficacy of the Walvax COVID-19 Vaccine is determined through clinical trials. The vaccine has shown to be effective in preventing COVID-19, particularly severe disease and hospitalization.

Side Effects

Common side effects of the Walvax COVID-19 Vaccine include pain at the injection site, fatigue, headache, muscle pain, chills, fever, and nausea. Serious side effects are rare but can occur.

Distribution

The Walvax COVID-19 Vaccine is distributed globally under the COVAX initiative, which aims to ensure equitable access to COVID-19 vaccines.

See Also

• COVID-19 pandemic
• COVID-19 vaccine
• Vaccine efficacy
• mRNA

References

<references />

External Links

• Walvax Biotechnology

   This article is a  stub. You can help WikiMD by expanding it!

This article is a stub related to pharmacology. You can help WikiMD by expanding it!